Healthy Clinical Trial
Official title:
To Evaluate the Intestinal Tolerance and Health Effects of Daily Consumption of Two Eggs With a Particular Fatty Acid Profile on a Set of Parameters Related to Metabolic Disorders
This study has two objectives: 1) to check that the daily consumption of two eggs with a
particular fatty acid pattern rich in n-3 polyunsaturated fatty acids (α-linolenic acid,
docosahexaenoic acid), conjugated-linoleic acid and conjugated-linolenic acid is well
tolerated by the consumer ; 2) to evaluate the effects of the consumption of these eggs on
health parameters in subjects presenting a risk of developing a metabolic disorder.
This monocentric study is an interventional, randomized, double-blind, control study.
n-3 polyunsaturated fatty acids, conjugated-linoleic acids and conjugated-linolenic acids
show interesting effects in the context of health. Indeed, some studies suggest positive
effects on circulating lipids or inflammation associated with certain disorders such as
diabetes, following the consumption of these fatty acids.
However, these fatty acids are not very present in the classic diet. Therefore, we have
developped hens eggs naturally enriched in n-3 polyunsaturated fatty acids,
conjugated-linoleic acids and conjugated-linolenic acids by changing the hens feed.
This study has two objectives: 1) to check that the daily consumption of two eggs with a
particular fatty acid pattern rich in n-3 polyunsaturated fatty acids (α-linolenic acid,
docosahexaenoic acid), conjugated-linoleic acid and conjugated-linolenic acid is well
tolerated by the consumer ; 2) to evaluate the effects of the consumption of these eggs on
health parameters in subjects presenting a risk of developing a metabolic disorder.
To do this, 80 subjects aged 35 to 75, sedentary (<2 hours of physical activity per week) and
with abdominal obesity (> 94cm for men and> 80cm for women) were recruited and were divided
into two groups: the control group (12 subjects consuming 2 classic eggs for 3 months per
day) or the test group (12 subjects consuming 2 eggs enriched in omega per day for 3 months).
A medical examination with blood sampling was scheduled every month at baseline (Day 0),
after one month (Day 30), after two months (Day 60) and at the end of the 3 months of
intervention (Day90). During those visits, the following were monitored: glucose parameters,
lipids parameters, fatty acid profile of red blood cells and plasma and safety parameters
related to haematology, kidney and liver functions .
During these monthly medical visits patients also completed the questionnaires assessing
intestinal tolerance (visual analogue scale showing 10 gastrointestinal symptoms), satiety
(visual analog scale questionnaire) and well-being (36 items short form survey). Eating
habits were monitored using a food diary. Additional parameters were measured only during the
first and the last visit: coagulation, nutritional status, endothelial function and
inflammation.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |